West Pharmaceutical Services Inc. Stock
West Pharmaceutical Services Inc. gained 2.170% today.
West Pharmaceutical Services Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
With a target price of 297 € there is a positive potential of 30.72% for West Pharmaceutical Services Inc. compared to the current price of 227.2 €.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | 2.170% | 1.519% | 13.147% | 22.315% | -3.030% | -31.360% | -9.338% |
| Haemonetics Corp. | 1.980% | 4.251% | -0.962% | - | -24.818% | - | - |
| Bio-Rad Labs Inc. A | 0.500% | 1.913% | 4.970% | 7.692% | -5.002% | -44.268% | -51.961% |
| CONMED Corp. | -0.610% | 8.725% | 0.000% | -28.319% | -7.429% | -67.107% | -70.545% |
Comments
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for WST provided by MarketBeat